Matthew I. Milowsky - UNC Lineberger

Dr. Matthew Milowsky, MD

Claim this profile

UNC Lineberger Comprehensive Cancer Center

Studies Bladder Cancer
Studies Transitional Cell Carcinoma
12 reported clinical trials
21 drugs studied

Area of expertise

1Bladder Cancer
Matthew Milowsky, MD has run 9 trials for Bladder Cancer. Some of their research focus areas include:
Stage IV
Stage III
PD-L1 negative
2Transitional Cell Carcinoma
Matthew Milowsky, MD has run 6 trials for Transitional Cell Carcinoma. Some of their research focus areas include:
Stage IV
Stage III
PD-L1 negative

Affiliated Hospitals

Image of trial facility.
UNC Lineberger Comprehensive Cancer Center
Image of trial facility.
Lineberger Comprehensive Cancer Center At University Of North Carolina - Chapel Hill

Clinical Trials Matthew Milowsky, MD is currently running

More about Matthew Milowsky, MD

Clinical Trial Related2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Matthew Milowsky, MD has experience with
  • Cisplatin
  • Gemcitabine
  • Pembrolizumab
  • Carboplatin
  • ATLCAR.CD30 Cells
  • Cyclophosphamid

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Milowsky, MD specialize in?
Matthew Milowsky, MD focuses on Bladder Cancer and Transitional Cell Carcinoma. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are Stage III.
Is Matthew Milowsky, MD currently recruiting for clinical trials?
Yes, Matthew Milowsky, MD is currently recruiting for 5 clinical trials in Chapel Hill North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Matthew Milowsky, MD has studied deeply?
Yes, Matthew Milowsky, MD has studied treatments such as Cisplatin, Gemcitabine, Pembrolizumab.
What is the best way to schedule an appointment with Matthew Milowsky, MD?
Apply for one of the trials that Matthew Milowsky, MD is conducting.
What is the office address of Matthew Milowsky, MD?
The office of Matthew Milowsky, MD is located at: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina 27514 United States. This is the address for their practice at the UNC Lineberger Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.